Advertisement

Cancer and Metastasis Reviews

, Volume 18, Issue 2, pp 215–230 | Cite as

Wnt Signalling in Mammalian Development and Cancer

  • Matthew J. Smalley
  • Trevor C. Dale
Article

Abstract

Wnt signalling is involved in a variety of mammalian developmental processes, including cell proliferation, differentiation and epithelial–mesenchymal interactions, through which they contribute to the development of tissues and organs such as the limbs, the brain, the reproductive tract and the kidney. Wnts are secreted ligands that control cell processes via at least two pathways, one of which, the ‘canonical’ Wnt signalling pathway, operates through the cytosolic stabilisation of a transcriptional co-factor, β-catenin. This is achieved by downregulating the activity of a β-catenin turnover complex. Evidence from tumour expression studies, transgenic animals and in vitro experiments suggests that inappropriate activation of the canonical Wnt signalling pathway is a major feature in human neoplasia and that oncogenic activation of this pathway can occur at many levels. Inappropriate expression of the Wnt ligand and Wnt binding proteins have been found in a variety of human tumours. Further downstream, dysregulation of the β-catenin turnover complex, by loss of the Adenomatous Polyposis Coli or Protein Phosphatase 2A proteins, or by activating mutations of β-catenin, has been found in several tumour types, and is believed to be a key step in neoplastic progression. Transcriptional targets of the Wnt pathway include the cellular oncogenes cyclin D1 and c-myc. Activation of the Wnt signalling pathway by various means can therefore be a primary cause in oncogenesis, affecting cell proliferation, morphology and contact inhibition, as well as co-operating with other oncogenes in multistep tumour progression.

transformation tumour Frizzled Dishevelled glycogen synthase kinase-3β 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wodarz A, Nusse R: Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59–88, 1998Google Scholar
  2. 2.
    Dale TC: Signal transduction by the Wnt family of ligands. Biochem J 329: 209–223, 1998Google Scholar
  3. 3.
    Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J Biol Chem 273: 10823–10826, 1998Google Scholar
  4. 4.
    Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17: 1371–1384, 1998Google Scholar
  5. 5.
    Hsu W, Zeng L, Costantini F: Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 274: 3439–3445, 1999Google Scholar
  6. 6.
    Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW: Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J Biol Chem 272: 24735–24738, 1997Google Scholar
  7. 7.
    Winston JT, Stack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW: The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Iκ Bα and β-catenin and stimulates Iκ Bα ubiquitination in vitro. Genes Dev 13: 270–283, 1999Google Scholar
  8. 8.
    Aberle H, Bauer A, Stappert J, Kispert A, Kemler R: β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797–3804, 1997Google Scholar
  9. 9.
    Hooper JE: Distinct pathways for autocrine and paracrine wingless signalling in Drosophila embryos. Nature 372: 461–464, 1994Google Scholar
  10. 10.
    Siegfried E, Wilder EL, Perrimon N: Components of wingless signalling in Drosophila. Nature 367: 76–80, 1994Google Scholar
  11. 11.
    Smalley MJ, Sara E, Paterson H, Naylor S, Cook D, Jayatilake H, Fryer LG, Hutchinson L, Fry MJ, Dale TC: Interaction of Axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J 18: 2823–2835, 1999Google Scholar
  12. 12.
    Strutt DI, Weber U, Mlodzik M: The role of RhoA in tissue polarity and Frizzled signalling. Nature 387: 292–295, 1997Google Scholar
  13. 13.
    Shulman JM, Perrimon N, Axelrod JD: Frizzled signaling and the developmental control of cell polarity. Trends Genet 14: 452–458, 1998Google Scholar
  14. 14.
    Boutros M, Paricio N, Strutt DI, Mlodzik M: Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 94: 109–118, 1998Google Scholar
  15. 15.
    Nusse R, Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99–109, 1982Google Scholar
  16. 16.
    Nusse R, Theunissen H, Wagenaar E, Rijsewijk F, Gennissen A, Otte A, Schuuring E, van Ooyen A: The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus. Mol Cell Biol 10: 4170–4179, 1990Google Scholar
  17. 17.
    Polakis P: The adenomatous polyposis coli (APC) tumor suppressor, Biochem Biophys Acta 1332: F127-F147, 1997Google Scholar
  18. 18.
    Polakis P: The oncogenic activation of β-catenin. Curr Opin Genet Dev 9: 15–21, 1999Google Scholar
  19. 19.
    Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787–1790, 1997Google Scholar
  20. 20.
    Tetsu O, McCormick F: B-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422–426, 1999Google Scholar
  21. 21.
    He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512, 1998Google Scholar
  22. 22.
    Bullions LC, Levine AJ: The role of β-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol 10: 81–87, 1998Google Scholar
  23. 23.
    Gavin BJ, McMahon JA, McMahon AP: Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev 4: 2319–2332, 1990Google Scholar
  24. 24.
    McMahon AP, Moon RT: Ectopic expression of the protooncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 58: 1057–1084, 1989Google Scholar
  25. 25.
    Smith WC, Harland RM: Injected Xwnt-8 RNA acts early in Xenopus embryos to promote formation of a vegetal dorsalizing center. Cell 67: 753–765, 1991Google Scholar
  26. 26.
    Sokol S, Christian JL, Moon RT, Melton DA: Injected Wnt RNA induces a complete body axis in Xenopus embryos. Cell 67: 741–752, 1991Google Scholar
  27. 27.
    Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J: Transformation by Wnt family proteins correlates with regulation of β-catenin. Cell Growth Differ 8: 1349–1358, 1997Google Scholar
  28. 28.
    Wong GT, Gavin BJ, McMahon AP: Differential transformation of mammary epithelial cells by Wnt genes. Mol Cell Biol 14: 6278–6286, 1994Google Scholar
  29. 29.
    Julius MA, Rai SD, Kitajewski J: Chimeric Wnt proteins define the amino-terminus of Wnt-1 as a transformation-specific determinant. Oncogene 18: 149–156, 1999Google Scholar
  30. 30.
    Torres MA, Yang-Snyder JA, Purcell SM, DeMarais AA, McGrew LL, Moon RT: Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5 A class and by a dominant negative cadherin in early Xenopus development. J Cell Biol 133: 1123–1137, 1996Google Scholar
  31. 31.
    Moon RT, Campbell RM, Christian JL, McGrew LL, Shih J, Fraser S: Xwnt-5A: a maternal Wnt that affects morphogenetic movements after overexpression in embryos of Xenopus laevis. Development 119: 97–111, 1993Google Scholar
  32. 32.
    Du SJ, Purcell SM, Christian JL, McGrew LL, Moon RT: Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos. Mol Cell Biol 15: 2625–2634, 1995Google Scholar
  33. 33.
    McMahon AP, Joyner AL, Bradley A, McMahon JA: The midbrain-hindbrain phenotype of Wnt-1 —/Wnt-1 — mice results from step wise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell 69: 581–595, 1992Google Scholar
  34. 34.
    Parr BA, McMahon AP: Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 395: 707–710, 1998Google Scholar
  35. 35.
    Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP: Female development in mammals is regulated by Wnt-4 signalling. Nature 397: 405–409, 1999Google Scholar
  36. 36.
    Yamaguchi TP, Bradley A, McMahon AP, Jones S: A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126: 1211–1223, 1999Google Scholar
  37. 37.
    Kengaku M, Capdevila J, Rodriguez-Esteban C, De La Pena J, Johnson RL, Belmonte JCI, Tabin CJ: Distinct WNT pathways regulating AER formation and dorsoventralpolarity in the chick limb bud. Science 280: 1274–1277, 1998Google Scholar
  38. 38.
    Kispert A, Vainio S, McMahon AP: Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development 125: 4225–4234, 1998Google Scholar
  39. 39.
    Lescher B, Haenig B, Kispert A: sFRP-2 is a target of the Wnt-4 signaling pathway in the developing metanephric kidney. Dev Dyn 213: 440–451, 1998Google Scholar
  40. 40.
    Herzlinger D, Qiao J, Cohen D, Ramakrishna N, Brown AM: Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. Dev Biol 166: 815–818, 1994Google Scholar
  41. 41.
    Stark K, Vainio S, Vassileva G, McMahon AP: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372: 679–683, 1994Google Scholar
  42. 42.
    Thesleff I, Sharpe P: Signalling networks regulating dental development. Mech Dev 67: 111–123, 1997Google Scholar
  43. 43.
    Thesleff I, Vaahtokari A, Kettunen P, Aberg T: Epithelial-mesenchymal signaling during tooth development. Connect Tissue Res 32: 9–15, 1995Google Scholar
  44. 44.
    Dassule HR, McMahon AP: Analysis of epithelial-mesenchymal interactions in the initial morphogenesis of the mammalian tooth. Dev Biol 202: 215–227, 1998Google Scholar
  45. 45.
    Gavin BJ, McMahon AP: Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Mol Cell Biol 12: 2418–2423, 1992Google Scholar
  46. 46.
    Weber-Hall SJ, Phippard DJ, Niemeyer CC, Dale TC: Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation 57: 205–214, 1994Google Scholar
  47. 47.
    Roelink H, Nusse R: Expression of two members of the Wnt family during mouse development — restricted temporal and spatial patterns in the developing neural tube. Genes Dev 5: 381–388, 1991Google Scholar
  48. 48.
    Parr BA, Shea MJ, Vassileva G, McMahon AP: Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 119: 247–261, 1993Google Scholar
  49. 49.
    Salinas PC, Nusse R: Regional expression of the Wnt-3 gene in the developing mouse forebrain in relationship to diencephalic neuromeres. Mech Dev 39: 151–160, 1992Google Scholar
  50. 50.
    Thomas KR, Capecchi MR: Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 346: 847–850, 1990Google Scholar
  51. 51.
    McMahon AP, Bradley A: The Wnt-1 (int-1) protooncogene is required for development of a large region of the mouse brain. Cell 62: 1073–1085, 1990Google Scholar
  52. 52.
    Dickinson ME, Krumlauf R, McMahon AP: Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system. Development 120: 1453–1471, 1994Google Scholar
  53. 53.
    Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S: Wnt signalling required for expansion of neural crest and CNS progenitors. Nature 389: 966–970, 1997Google Scholar
  54. 54.
    Smolich BD, Papkoff J: Regulated expression of Wnt family members during neuroectodermal differentiation of P19 embryonal carcinoma cells: overexpression of Wnt-1 perturbs normal differentiation-specific properties. Dev Biol 166: 300–310, 1994Google Scholar
  55. 55.
    Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H: Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19: 379–383, 1998Google Scholar
  56. 56.
    Katoh M, Hirai M, Sugimura T, Terada M: Cloning, expression and chromosomal localization of Wnt-13, a novel member of the Wnt gene family. Oncogene 13: 873–876, 1996Google Scholar
  57. 57.
    Ikegawa S, Kumano Y, Okui K, Fujiwara T, Takahashi E, Nakamura Y: Isolation, characterization and chromosomal assignment of the human WNT7A gene. Cytogenet Cell Genet 74: 149–152, 1996Google Scholar
  58. 58.
    Shackleford GM, Varmus HE: Expression of the protooncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos. Cell 50: 89–95, 1987Google Scholar
  59. 59.
    Bui TD, Zhang L, Rees MC, Bicknell R, Harris AL: Expression and hormone regulation of Wnt 2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer 75: 1131–1136, 1997Google Scholar
  60. 60.
    Vider BZ, Zimber A, Chastre E, Prevot S, Gespach C, Estlein D, Wolloch Y, Tronick SR, Gazit A, Yaniv A: Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 12: 153–158, 1996Google Scholar
  61. 61.
    Miller SE, Willert K, Salinas PC, Roelink H, Nusse R, Sussman DJ, Barsh GS: WNT signaling in the control of hair growth and structure. Dev Biol 207: 133–149, 1999Google Scholar
  62. 62.
    Miller C, Sassoon DA: Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125: 3201–3211, 1998Google Scholar
  63. 63.
    Saitoh A, Hansen LA, Vogel JC, Udey MC: Characterization of Wnt gene expression in murine skin: possible involvement of epidermis-derived Wnt-4 in cutaneous epithelial-mesenchymal interactions. Exp Cell Res 243: 150–160, 1998Google Scholar
  64. 64.
    Austin TW, Solar GP, Ziegler FC, Liem L, Matthews W: A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89: 3624–3635, 1997Google Scholar
  65. 65.
    Sakakura T, Kusano I, Kusakabe M, Inaguma Y, Nishizuka Y: Biology of mammary fat pad in fetal mouse: capacity to support development of various fetal epithelia in vivo. Development 100: 421–430, 1987Google Scholar
  66. 66.
    Van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, Bruhn L, Grosschedl R: Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8: 2691–2703, 1994Google Scholar
  67. 67.
    Bradbury JM, Edwards PA, Niemeyer CC, Dale TC: Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol 170: 553–563, 1995Google Scholar
  68. 68.
    Lejeune S, Huguet EL, Hamby A, Poulsom R, Harris AL: Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res 1: 215–222, 1995Google Scholar
  69. 69.
    Iozzo RV, Eichstetter I, Danielson KG: Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 55: 3495–3499, 1995Google Scholar
  70. 70.
    Bui TD, O'Brien T, Crew J, Cranston D, Harris AL: High expression of Wnt7B in human superficial bladder cancer vs invasive bladder cancer. Br J Cancer 77: 319–324, 1998Google Scholar
  71. 71.
    Dale TC, Weber-Hall SJ, Smith K, Huguet EL, Jayatilake H, Gusterson BA, Shuttleworth G, O'Hare M, Harris AL: Compartment switching of WNT-2 expression in human breast tumors. Cancer Res 56: 4320–4323, 1996Google Scholar
  72. 72.
    Huguet EL, McMahon JA, McMahon AP, Bicknell R, Harris AL: Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res 54: 2615–2621, 1994Google Scholar
  73. 73.
    Shackleford GM, MacArthur CA, Kwan HC, Varmus HE: Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. Proc Natl Acad Sci USA 90: 740–744, 1993Google Scholar
  74. 74.
    Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619–625, 1988Google Scholar
  75. 75.
    Kwan H, Pecenka V, Tsukamoto A, Parslow TG, Guzman R, Lin TP, Muller WJ, Lee FS, Leder P, Varmus HE: Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol 12: 147–154, 1992Google Scholar
  76. 76.
    Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D, Varmus HE: Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9: 882–895, 1995Google Scholar
  77. 77.
    MacArthur CA, Shankar DB, Shackleford GM: Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J Virol 69: 2501–2507, 1995Google Scholar
  78. 78.
    Roelink H, Wagenaar E, Nusse R: Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Oncogene 7: 487–492, 1992Google Scholar
  79. 79.
    Edwards PA, Hiby SE, Papkoff J, Bradbury JM: Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland. Oncogene 7: 2041–2051, 1992Google Scholar
  80. 80.
    Shibamoto S, Higano K, Takada R, Ito F, Takeichi M, Takada S: Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 3: 659–670, 1998Google Scholar
  81. 81.
    Blasband A, Schryver B, Papkoff J: The biochemical properties and transforming potential of human Wnt-2 are similar to Wnt-1. Oncogene 7: 153–161, 1992Google Scholar
  82. 82.
    Brown AM, Wildin RS, Prendergast TJ, Varmus HE: A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line. Cell 46: 1001–1009, 1986Google Scholar
  83. 83.
    Young CS, Kitamura M, Hardy S, Kitajewski J: Wnt-1 induces growth, cytosolic β-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol 18: 2474–2485, 1998Google Scholar
  84. 84.
    Bradbury JM, Niemeyer CC, Dale TC, Edwards PA: Alterations of the growth characteristics of the fibroblast cell line C3H 10T1/2 by members of the Wnt gene family. Oncogene 9: 2597–2603, 1994Google Scholar
  85. 85.
    Bafico A, Gazit A, Wu-Morgan SS, Yaniv A, Aaronson SA: Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene 16: 2819–2825, 1998Google Scholar
  86. 86.
    Olson DJ, Gibo DM, Saggers G, Debinski W, Kumar R: Reversion of uroepithelial cell tumorigenesis by the ectopic expression of human wnt-5a. Cell Growth Differ 8: 417–423, 1997Google Scholar
  87. 87.
    Olson DJ, Gibo DM: Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation. Exp Cell Res 241: 134–141, 1998Google Scholar
  88. 88.
    Huguet EL, Smith K, Bicknell R, Harris AL: Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor. J Biol Chem 270: 12851–12856, 1995Google Scholar
  89. 89.
    Jonsson M, Smith K, Harris AL: Regulation of Wnt5a expression in human mammary cells by protein kinase C activity and the cytoskeleton. Br J Cancer 78: 430–438, 1998Google Scholar
  90. 90.
    Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R: A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382: 225–230, 1996Google Scholar
  91. 91.
    Hsieh JC, Rattner A, Smallwood PM, Nathans J: Biochemical characterization of Wnt-Frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci USA 96: 3546–3451, 1999Google Scholar
  92. 92.
    He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H: A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 275: 1652–1654, 1997Google Scholar
  93. 93.
    Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA: Structure and function of G protein-coupled receptors. Annu Rev Biochem 63: 101–132, 1994Google Scholar
  94. 94.
    Slusarski DC, Corces VG, Moon RT: Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390: 410–413, 1997Google Scholar
  95. 95.
    Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J: A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci USA 94: 2859–2863, 1997Google Scholar
  96. 96.
    Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, Tomei LD, Umansky SR: SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci USA 94: 13636–13641, 1997Google Scholar
  97. 97.
    Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, Rudikoff S, Aaronson SA, Varmus HE, Rubin JS: Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci USA 94: 6770–6775, 1997Google Scholar
  98. 98.
    Hu E, Zhu Y, Fredrickson T, Barnes M, Kelsell D, Beeley L, Brooks D: Tissue restricted expression of two human Frzbs in preadipocytes and pancreas (published erratum appears in Biochem Biophys Res Commun 1998 Jul 30; 248(3): 941–943). Biochem Biophys Res Commun 247: 287–293, 1998Google Scholar
  99. 99.
    Chang JT, Esumi N, Moore K, Li Y, Zhang S, Chew C, Goodman B, Rattner A, Moody S, Stetten G, Campochiaro PA, Zack DJ: Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium. Hum Mol Genet 8: 575–583, 1999Google Scholar
  100. 100.
    Wang S, Krinks M, Lin K, Luyten FP, Moos M, Jr.: Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell 88: 757–766, 1997Google Scholar
  101. 101.
    Wang S, Krinks M, Moos M, Jr.: Frzb-1, an antagonist of Wnt-1 and Wnt-8, does not block signaling by Wnts-3A,-5A, or-11. Biochem Biophys Res Commun 236: 502–504, 1997Google Scholar
  102. 102.
    Salic AN, Kroll KL, Evans LM, Kirschner MW: Sizzled: a secreted Xwnt8 antagonist expressed in the ventral marginal zone of Xenopus embryos. Development 124: 4739–4748, 1997Google Scholar
  103. 103.
    Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C: Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391: 357–362, 1998Google Scholar
  104. 104.
    Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, Nusse R, Dawid IB, Nathans J: A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398: 431–436, 1999Google Scholar
  105. 105.
    Sagara N, Toda G, Hirai M, Terada M, Katoh M: Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7. Biochem Biophys Res Commun 252: 117–122, 1998Google Scholar
  106. 106.
    Wang Y, Macke JP, Abella BS, Andreasson K, Worley P, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J: A large family of putative transmembrane receptors homologous to the product of the Drosophila tissue polarity gene frizzled. J Biol Chem 271: 4468–4476, 1996Google Scholar
  107. 107.
    Wang YK, Sporle R, Paperna T, Schughart K, Francke U: Characterization and expression pattern of the frizzled gene Fzd9, the mouse homolog of FZD9 which is deleted in Williams-Beuren syndrome. Genomics 57: 235–248, 1999Google Scholar
  108. 108.
    Tokuhara M, Hirai M, Atomi Y, Terada M, Katoh M: Molecular cloning of human Frizzled-6. Biochem Biophys Res Commun 243: 622–627, 1998Google Scholar
  109. 109.
    Zhao Z, Lee CC, Baldini A, Caskey CT: A human homologue of the Drosophila polarity gene frizzled has been identified and mapped to 17q21.1. Genomics 27: 370–373, 1995Google Scholar
  110. 110.
    Tanaka S, Akiyoshi T, Mori M, Wands JR, Sugimachi K: A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals. Proc Natl Acad Sci USA 95: 10164–10169, 1998Google Scholar
  111. 111.
    Ugolini F, Adelaide J, Charafe-Jauffret E, Nguyen C, Jacquemier J, Jordan B, Birnbaum D, Pebusque MJ: Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1(FGFR1) as candidate breast cancer genes. Oncogene 18: 1903–1910, 1999Google Scholar
  112. 112.
    Abu-Jawdeh G, Comella N, Tomita Y, Brown LF, Tognazzi K, Sokol SY, Kocher O: Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy. Lab Invest 79: 439–447, 1999Google Scholar
  113. 113.
    Sussman DJ, Klingensmith J, Salinas P, Adams PS, Nusse R, Perrimon N: Isolation and characterization of a mouse homolog of the Drosophila segment polarity gene dishevelled. Dev Biol 166: 73–86, 1994Google Scholar
  114. 114.
    Theisen H, Purcell J, Bennett M, Kansagara D, Syed A, Marsh JL: dishevelled is required during wingless signaling to establish both cell polarity and cell identity. Development 120: 347–360, 1994Google Scholar
  115. 115.
    Klingensmith J, Nusse R, Perrimon N: The Drosophila segment polarity gene dishevelled encodes a novel protein required for response to the wingless signal. Genes Dev 8: 118–130, 1994Google Scholar
  116. 116.
    Axelrod JD, Miller JR, Shulman JM, Moon RT, Perrimon N: Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and Wingless signaling pathways. Genes Dev 12: 2610–2622, 1998Google Scholar
  117. 117.
    Saras J, Heldin CH: PDZ domains bind carboxy-terminal sequences of target proteins. Trends Biochem Sci 21: 455–458, 1996Google Scholar
  118. 118.
    Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH, Crompton A, Chan AC, Anderson JM, Cantley LC: Recognition of unique carboxyl-terminal motifs by distinct PDZ domains, Science 275: 73–77, 1997Google Scholar
  119. 119.
    Ponting CP, Bork P: Pleckstrin's repeat performance: a novel domain in G-protein signaling? Trends Biochem Sci 21: 245–246, 1996Google Scholar
  120. 120.
    Yang-Snyder J, Miller JR, Brown JD, Lai CJ, Moon RT: A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol 6: 1302–1306, 1996Google Scholar
  121. 121.
    Li L, Yuan H, Xie W, Mao J, Caruso AM, McMahon A, Sussman DJ, Wu D: Dishevelled proteins lead to two signaling pathways. Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells. J Biol Chem 274: 129–134, 1999Google Scholar
  122. 122.
    Yanagawa S, van Leeuwen F, Wodarz A, Klingensmith J, Nusse R: The dishevelled protein is modified by wingless signaling in Drosophila. Genes Dev 9: 1087–1097, 1995Google Scholar
  123. 123.
    Steitz SA, Tsang M, Sussman DJ: Wnt-mediated relocalization of dishevelled proteins. In vitro Cell Dev Biol Anim 32: 441–445, 1996Google Scholar
  124. 124.
    Willert K, Brink M, Wodarz A, Varmus H, Nusse R: Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J 16: 3089–3096, 1997Google Scholar
  125. 125.
    Fagotto F, Jho E, Zeng L, Kurth T, Joos T, Kaufmann C, Costantini F: Domains of Axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol 145: 741–756, 1999Google Scholar
  126. 126.
    Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A: Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3β regulates its stability. J Biol Chem 274: 10681–10684, 1999Google Scholar
  127. 127.
    Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A: Social interaction and sensorimotor gating abnormalities in mice lacking Dvll. Cell 90: 895–905, 1997Google Scholar
  128. 128.
    Tsang M, Lijam N, Yang Y, Beier DR, Wynshaw-Boris A, Sussman DJ: Isolation and characterization of mouse dishevelled-3. Dev Dyn 207: 253–262, 1996Google Scholar
  129. 129.
    Bui TD, Beier DR, Jonssen M, Smith K, Dorrington SM, Kaklamanis L, Kearney L, Regan R, Sussman DJ, Harris AL: cDNA cloning of a human dishevelled DVL-3 gene, mapping to 3q27, and expression in human breast and colon carcinomas. Biochem Biophys Res Commun 239: 510–516, 1997Google Scholar
  130. 130.
    Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W: Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science 280: 596–599, 1998Google Scholar
  131. 131.
    Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM: Regulation of β-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283: 2089–2091, 1999Google Scholar
  132. 132.
    Kishida S, Yamamoto H, Hino S, Ikeda S, Kishida M, Kikuchi A: DIX domains of dvl and axin are necessary for protein interactions and their ability to regulate β-catenin stability. Mol Cell Biol 19: 4414–4422, 1999Google Scholar
  133. 133.
    Sakanaka C, Williams LT: Functional domains of axin. Importance Of the c terminus as an oligomerization domain. J Biol Chem 274: 14090–14093, 1999Google Scholar
  134. 134.
    Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P: Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β. Curr Biol 8: 573–581, 1998Google Scholar
  135. 135.
    van Es JH, Kirkpatrick C, van de Wetering M, Molenaar M, Miles A, Kuipers J, Destree O, Peifer M, Clevers H: Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. Curr Biol 9: 105–108, 1999Google Scholar
  136. 136.
    Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F: The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181–192, 1997Google Scholar
  137. 137.
    Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M, Kikuchi A: Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3β and β-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol 18: 2867–2875, 1998Google Scholar
  138. 138.
    Mai M, Qian C, Yokomizo A, Smith DI, Liu W: Cloning of the human homolog of conductin (AXIN 2), a gene mapping to chromosome 17q23-q24. Genomics 55: 341–344, 1999Google Scholar
  139. 139.
    Luongo C, Moser AR, Gledhill S, Dove WF: Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54: 5947–5952, 1994Google Scholar
  140. 140.
    Oshima H, Oshima M, Kobayashi M, Tsutsumi M, Taketo MM: Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice. Cancer Res 57: 1644–1649, 1997Google Scholar
  141. 141.
    Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A: The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522–5527, 1999Google Scholar
  142. 142.
    Issack PS, Ziff EB: Altered expression of helix-loop-helix transcriptional regulators and cyclin D1 in Wnt-1-transformed PC12 cells. Cell Growth Differ 9: 837–845, 1998Google Scholar
  143. 143.
    Diehl JA, Cheng M, Roussel MF, Sherr CJ: Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499–3511, 1998Google Scholar
  144. 144.
    Barnes DM, Gillett CE: Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1–15, 1998Google Scholar
  145. 145.
    Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C: Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9: 2364–2372, 1995Google Scholar
  146. 146.
    Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671, 1994Google Scholar
  147. 147.
    Pennica D, Swanson TA, Welsh JW, Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, Watanabe C, Cohen RL, Melhem MF, Finley GG, Quirke P, Goddard AD, Hillan KJ, Gurney AL, Botstein D, Levine AJ: WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95: 14717–14722, 1998Google Scholar
  148. 148.
    Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJH, Rubinfeld B, Polakis P, Matrisian LM: The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumours. Oncogene 18: 2883–2891, 1999Google Scholar
  149. 149.
    Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S: Regulation of cell adhesion and anchorage-dependent growth by a new β 1-integrin-linked protein kinase. Nature 379: 91–96, 1996Google Scholar
  150. 150.
    Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S: Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc Natl Acad Sci USA 95: 4374–4379, 1998Google Scholar
  151. 151.
    Papkoff J, Aikawa M: WNT-1 and HGF regulate GSK3 β activity and β-catenin signaling in mammary epithelial cells. Biochem Biophys Res Commun 247: 851–858, 1998Google Scholar
  152. 152.
    Kim E, Arnould T, Sellin LK, Benzing T, Fan MJ, Griming W, Sokol SY, Drummond I, Walz G: The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 274: 4947–4953, 1999Google Scholar
  153. 153.
    Jonkers J, Korswagen HC, Acton D, Breuer M, Berns A: Activation of a novel proto-oncogene, Fratl, contributes to progression of mouse T-cell lymphomas. EMBO J 16: 441–450, 1997Google Scholar
  154. 154.
    Yost C, Farr GH, 3rd, Pierce SB, Ferkey DM, Chen MM, Kimelman D: GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 93: 1031–1041, 1998Google Scholar
  155. 155.
    Yu X, Riese J, Eresh S, Bienz M: Transcriptional repression due to high levels of Wingless signalling. EMBO J 17: 7021–7032, 1998Google Scholar
  156. 156.
    Frittitta L, Cerrato A, Sacco MG, Weidner N, Goldfine ID, Vigneri R: The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice. Breast Cancer Res Treat 45: 141–147, 1997Google Scholar
  157. 157.
    Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID, Vigneri R: Elevated insulin receptor content in human breast cancer. J Clin Invest 86: 1503–1510, 1990Google Scholar
  158. 158.
    Goodfellow PJ: Inherited cancers associated with the RET proto-oncogene. Curr Opin Genet Dev 4: 446–452, 1994Google Scholar
  159. 159.
    Donis-Keller H: The RET proto-oncogene and cancer. J Intern Med 238: 319–325, 1995Google Scholar
  160. 160.
    Zheng S, Ramachandran B, Haigh JR, Palos TP, Steger K, Howard BD: The induction of ret by Wnt-1 in PC 12 cells is atypically dependent on continual Wnt-1 expression. Oncogene 12: 555–562, 1996Google Scholar
  161. 161.
    Marsh SK, Bansal GS, Zammit C, Barnard R, Coope R, Roberts-Clarke D, Gomm JJ, Coombes RC, Johnston CL: Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene 18: 1053–1060, 1999Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Matthew J. Smalley
    • 1
  • Trevor C. Dale
    • 1
  1. 1.Developmental Biology Team, Institute of Cancer Research, The Breakthrough Toby Robins Breast Cancer Research Centre, Chester Beatty LaboratoriesLondonUK

Personalised recommendations